Literature DB >> 17249692

Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.

Leyla Celik1, Julie Davey Dalsgaard Lund, Birgit Schiøtt.   

Abstract

We present 158 ns of unrestrained all-atom molecular dynamics (MD) simulations of the human estrogen receptor alpha ligand binding domain (ERalpha LBD) sampling the conformational changes upon binding of estradiol. The pivotal role of His524 in maintaining the protein structure in the biologically active agonist conformation is elucidated. With His524 modeled as the epsilon-tautomer, a conserved hydrogen bond to the ligand is found in the active complex. Helices 3 and 11 are held together by a hydrogen-bonding network from His524 to Glu339 via Glu419 and Lys531, arresting the ligand in the binding pocket and creating the "mouse trap" binding site for helix 12 (H12). The simulations reveal how His524 serves as a communication point between the two. When estradiol is bound, His524 is positioned correctly for the hydrogen bond network to be established. H12 is then positioned for interaction with the co-activator protein, leading to the biologically active complex. The conformational dynamics of ERalpha LBD is further investigated from simulations of antagonist and apo conformations of the protein. These simulations suggest a likely sequence of events for the transition from the inactive apo structure to the transcriptionally active conformation of ERalpha LBD. Stable conformations are identified where H12 is placed neither in the "mouse trap" nor in the co-activator binding groove, as is the case for antagonist structures of ERalpha LBD. Finally, the influence of such conformations on the biological function of ERalpha is discussed in relationship to the interaction with selective estrogen receptor modulators and endocrine-disrupting compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17249692     DOI: 10.1021/bi061656t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Structural modeling of high-affinity thyroid receptor-ligand complexes.

Authors:  Alexandre Suman de Araujo; Leandro Martínez; Ricardo de Paula Nicoluci; Munir S Skaf; Igor Polikarpov
Journal:  Eur Biophys J       Date:  2010-05-30       Impact factor: 1.733

2.  Accurate prediction of the bound form of the Akt pleckstrin homology domain using normal mode analysis to explore structural flexibility.

Authors:  Hoang T Tran; Shuxing Zhang
Journal:  J Chem Inf Model       Date:  2011-08-25       Impact factor: 4.956

3.  Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange.

Authors:  A C M Figueira; D M Saidemberg; P C T Souza; L Martínez; T S Scanlan; J D Baxter; M S Skaf; M S Palma; P Webb; I Polikarpov
Journal:  Mol Endocrinol       Date:  2010-11-24

4.  Efficient metal-specific transcription activation by Drosophila MTF-1 requires conserved cysteine residues in the carboxy-terminal domain.

Authors:  Sharon K Marr; Katie L Pennington; Michael T Marr
Journal:  Biochim Biophys Acta       Date:  2012-03-28

5.  Structure of estradiol metal chelate and estrogen receptor complex: the basis for designing a new class of selective estrogen receptor modulators.

Authors:  Min-Jun Li; Harry M Greenblatt; Orly Dym; Shira Albeck; Adi Pais; Chidambaram Gunanathan; David Milstein; Hadassa Degani; Joel L Sussman
Journal:  J Med Chem       Date:  2011-04-19       Impact factor: 7.446

6.  Histone H2A.Z is essential for estrogen receptor signaling.

Authors:  Nicolas Gévry; Sara Hardy; Pierre-Etienne Jacques; Liette Laflamme; Amy Svotelis; François Robert; Luc Gaudreau
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

7.  Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method.

Authors:  Shin-ichi Fujiwara; Takashi Amisaki
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

8.  Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.

Authors:  Liying Zhang; Alexander Sedykh; Ashutosh Tripathi; Hao Zhu; Antreas Afantitis; Varnavas D Mouchlis; Georgia Melagraki; Ivan Rusyn; Alexander Tropsha
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-23       Impact factor: 4.219

9.  Substrate binding and formation of an occluded state in the leucine transporter.

Authors:  Leyla Celik; Birgit Schiøtt; Emad Tajkhorshid
Journal:  Biophys J       Date:  2007-11-16       Impact factor: 4.033

Review 10.  Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer.

Authors:  Sergio C Chai; William C Wright; Taosheng Chen
Journal:  Med Res Rev       Date:  2019-11-28       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.